Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• The gut microbiota plays a crucial role in host physiology, interacting with the central nervous system (CNS) via the microbiota-gut-brain axis.
• Dysregulation of this axis is increasingly implicated in the pathogenesis of various CNS disorders.

Purpose of the Study:

• To provide an overview of the microbiota-gut-brain axis in health and disease.
• To review the axis's relevance to neurodegenerative diseases, particularly Parkinson's disease.
• To assess the therapeutic potential of targeting the gut microbiota.

Main Methods:

• Literature review of animal models and human studies.
• Analysis of the mechanistic links between gut microbiota and CNS function.
• Evaluation of current evidence for microbiota-targeted interventions.

Main Results:

• The microbiota-gut-brain axis is well-established in animal models, but human evidence remains limited due to logistical challenges.
• Disturbed gut microbiota has been implicated in CNS disorders, including Parkinson's disease, though human data is scarce.
• Theoretical frameworks support microbiota-directed therapies for neurodegenerative disorders, but high-quality clinical trial data is lacking.

Conclusions:

• The microbiota-gut-brain axis is a plausible factor in neurodegenerative diseases, but requires further clinical validation.
• Targeting the gut microbiota represents a potential therapeutic strategy for conditions like Parkinson's disease.
• Future research should focus on robust clinical trials to confirm the efficacy of microbiota-based interventions.